<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="161737-2018"
            EDITION="2018073">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-164399-001</RECEPTION_ID>
      <DELETION_DATE>20180721</DELETION_DATE>
      <FORM_LG_LIST>DE </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>73</NO_OJ>
         <DATE_PUB>20180414</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 073-161737</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="DE">http://ted.europa.eu/udl?uri=TED:NOTICE:161737-2018:TEXT:DE:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>DE</LG_ORIG>
         <ISO_COUNTRY VALUE="DE"/>
         <IA_URL_GENERAL>http://www.aok.de/baden-wuerttemberg</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="DE">DEUTSCHLAND</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="DE">DEUTSCHLAND</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="DE">DEUTSCHLAND</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="UK">UNITED KINGDOM</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="BE">BELGIQUE-BELGIË</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">209000.00</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 240-497692</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180412</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="4">European Union</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Гepмaния</TI_CY>
            <TI_TOWN>Щутгарт</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Německo</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Tyskland</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Deutschland</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Γερμανία</TI_CY>
            <TI_TOWN>Στουτγάρδη</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Germany</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Alemania</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Saksamaa</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Saksa</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Allemagne</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Ghearmáin, an</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Njemačka</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Németország</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Germania</TI_CY>
            <TI_TOWN>Stoccarda</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Vokietija, VFR</TI_CY>
            <TI_TOWN>Štutgartas</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Vācija</TI_CY>
            <TI_TOWN>Štutgarte</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>il-Ġermanja</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Duitsland</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Niemcy</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Alemanha</TI_CY>
            <TI_TOWN>Estugarda</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Germania</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Nemecko</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Nemčija</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Tyskland</TI_CY>
            <TI_TOWN>Stuttgart</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="DE">AOK Baden-Württemberg</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="DE">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>AOK Baden-Württemberg</OFFICIALNAME>
               <ADDRESS>Presselstr. 19</ADDRESS>
               <TOWN>Stuttgart</TOWN>
               <POSTAL_CODE>70191</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <CONTACT_POINT>Frank Wienands</CONTACT_POINT>
               <E_MAIL>arzneimittel@bw.aok.de</E_MAIL>
               <n2016:NUTS CODE="DE"/>
               <URL_GENERAL>http://www.aok.de/baden-wuerttemberg</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY_ADDITIONAL>
               <OFFICIALNAME>AOK Bayern – Die Gesundheitskasse</OFFICIALNAME>
               <ADDRESS>Carl-Wery-Str. 28</ADDRESS>
               <TOWN>München</TOWN>
               <POSTAL_CODE>81739</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <E_MAIL>arzneimittel@bw.aok.de</E_MAIL>
               <n2016:NUTS CODE="DE"/>
               <URL_GENERAL>http://www.aok.de/baden-wuerttemberg</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY_ADDITIONAL>
            <ADDRESS_CONTRACTING_BODY_ADDITIONAL>
               <OFFICIALNAME>AOK – Die Gesundheitskasse in Hessen</OFFICIALNAME>
               <ADDRESS>Basler Straße 2</ADDRESS>
               <TOWN>Bad Homburg</TOWN>
               <POSTAL_CODE>61352</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <E_MAIL>arzneimittel@bw.aok.de</E_MAIL>
               <n2016:NUTS CODE="DE"/>
               <URL_GENERAL>http://www.aok.de/baden-wuerttemberg</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY_ADDITIONAL>
            <ADDRESS_CONTRACTING_BODY_ADDITIONAL>
               <OFFICIALNAME>AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen</OFFICIALNAME>
               <ADDRESS>Sternplatz 7</ADDRESS>
               <TOWN>Dresden</TOWN>
               <POSTAL_CODE>01067</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <E_MAIL>arzneimittel@bw.aok.de</E_MAIL>
               <n2016:NUTS CODE="DE"/>
               <URL_GENERAL>http://www.aok.de/baden-wuerttemberg</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY_ADDITIONAL>
            <ADDRESS_CONTRACTING_BODY_ADDITIONAL>
               <OFFICIALNAME>AOK NordWest – Die Gesundheitskasse</OFFICIALNAME>
               <ADDRESS>Kopenhagener Straße 1</ADDRESS>
               <TOWN>Dortmund</TOWN>
               <POSTAL_CODE>44269</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <E_MAIL>arzneimittel@bw.aok.de</E_MAIL>
               <n2016:NUTS CODE="DE"/>
               <URL_GENERAL>http://www.aok.de/baden-wuerttemberg</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY_ADDITIONAL>
            <ADDRESS_CONTRACTING_BODY_ADDITIONAL>
               <OFFICIALNAME>AOK Rheinland/Hamburg – Die Gesundheitskasse</OFFICIALNAME>
               <ADDRESS>Kasernenstraße 31</ADDRESS>
               <TOWN>Düsseldorf</TOWN>
               <POSTAL_CODE>40213</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <E_MAIL>arzneimittel@bw.aok.de</E_MAIL>
               <n2016:NUTS CODE="DE"/>
               <URL_GENERAL>http://www.aok.de/baden-wuerttemberg</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY_ADDITIONAL>
            <ADDRESS_CONTRACTING_BODY_ADDITIONAL>
               <OFFICIALNAME>AOK Bremen/Bremerhaven</OFFICIALNAME>
               <ADDRESS>Bürgermeister-Smidt-Straße 95</ADDRESS>
               <TOWN>Bremen</TOWN>
               <POSTAL_CODE>28195</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <E_MAIL>arzneimittel@bw.aok.de</E_MAIL>
               <n2016:NUTS CODE="DE"/>
               <URL_GENERAL>http://www.aok.de/baden-wuerttemberg</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY_ADDITIONAL>
            <ADDRESS_CONTRACTING_BODY_ADDITIONAL>
               <OFFICIALNAME>AOK – Die Gesundheitskasse für Niedersachsen</OFFICIALNAME>
               <ADDRESS>Hildesheimer Straße 273</ADDRESS>
               <TOWN>Hannover</TOWN>
               <POSTAL_CODE>30519</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <E_MAIL>arzneimittel@bw.aok.de</E_MAIL>
               <n2016:NUTS CODE="DE"/>
               <URL_GENERAL>http://www.aok.de/baden-wuerttemberg</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY_ADDITIONAL>
            <ADDRESS_CONTRACTING_BODY_ADDITIONAL>
               <OFFICIALNAME>AOK Sachsen-Anhalt – Die Gesundheitskasse</OFFICIALNAME>
               <ADDRESS>Lüneburger Straße 4</ADDRESS>
               <TOWN>Magdeburg</TOWN>
               <POSTAL_CODE>39106</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <E_MAIL>arzneimittel@bw.aok.de</E_MAIL>
               <n2016:NUTS CODE="DE"/>
               <URL_GENERAL>http://www.aok.de/baden-wuerttemberg</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY_ADDITIONAL>
            <ADDRESS_CONTRACTING_BODY_ADDITIONAL>
               <OFFICIALNAME>AOK Nordost – Die Gesundheitskasse</OFFICIALNAME>
               <ADDRESS>Behlertstraße 33A</ADDRESS>
               <TOWN>Potsdam</TOWN>
               <POSTAL_CODE>14467</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <E_MAIL>arzneimittel@bw.aok.de</E_MAIL>
               <n2016:NUTS CODE="DE"/>
               <URL_GENERAL>http://www.aok.de/baden-wuerttemberg</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY_ADDITIONAL>
            <ADDRESS_CONTRACTING_BODY_ADDITIONAL>
               <OFFICIALNAME>AOK Rheinland-Pfalz/Saarland – Die Gesundheitskasse</OFFICIALNAME>
               <ADDRESS>Virchowstr. 30</ADDRESS>
               <TOWN>Eisenberg</TOWN>
               <POSTAL_CODE>67304</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <E_MAIL>arzneimittel@bw.aok.de</E_MAIL>
               <n2016:NUTS CODE="DE"/>
               <URL_GENERAL>http://www.aok.de/baden-wuerttemberg</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY_ADDITIONAL>
            <JOINT_PROCUREMENT_INVOLVED/>
            <PROCUREMENT_LAW>
               <P>Abschluss von Rabattvereinbarungen gem. § 130a Abs. 8 SGB V für den Zeitraum vom 1.10.2018 bis zum 30.9.2020</P>
            </PROCUREMENT_LAW>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Abschluss von Rabattverträgen gemäß § 130a Abs. 8 SGB V für Arzneimittel im generischen Markt</P>
            </TITLE>
            <REFERENCE_NUMBER>AOK XX</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Abschluss von Rabattvereinbarungen gem. § 130a Abs. 8 SGB V für den Zeitraum 1.10.2018 bis 30.9.2020 (AOK XX). Die Ausschreibung erfolgt wirkstoffbezogen für u. g. 62 Fachlose. Jeder Wirkstoff stellt grundsätzlich ein eigenes Fachlos dar, soweit Besonderheiten nicht gesondert benannt werden. Für jedes Fachlos werden acht Teillose (Gebietslose) gemäß näherer Bestimmung in den Vergabeunterlagen gebildet. Die Bieter entscheiden selbst, für welche/s Fachlos/e und welche/s Gebietslos/e sie Rabattangebote abgeben wollen. Die Zuschlagserteilung erfolgt pro Fach- und Gebietslos. Pro Fachlos-und Gebietslos-Kombination werden je nach Fachlos gemäß näherer Bestimmung in den Vergabeunterlagen Rabattverträge mit einem oder - das Vorliegen zuschlagsfähiger Angebote in ausreichender Zahl vorausgesetzt – mit bis zu drei pharmazeutischen Unternehmern geschlossen. Die genaue Definition des Beschaffungsbedarfs ergibt sich i. Ü. aus den Vergabeunterlagen.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            <LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>Candesartan</P>
               </TITLE>
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>Es wird auf die kurze Beschreibung des Auftragsgegenstandes (s. o.) sowie insbesondere auf Folgendes hingewiesen:</P>
                  <P>Für den ausschreibungsgegenständlichen Wirkstoff werden acht Teillose (Gebietslose) gebildet, und zwar wie folgt:</P>
                  <P>Gebietslos 1: AOK Bayern – Die Gesundheitskasse;</P>
                  <P>Gebietslos 2: AOK – Die Gesundheitskasse in Hessen, AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen;</P>
                  <P>Gebietslos 3: AOK Baden-Württemberg;</P>
                  <P>Gebietslos 4: AOK NordWest – Die Gesundheitskasse;</P>
                  <P>Gebietslos 5: AOK Rheinland/Hamburg – Die Gesundheitskasse;</P>
                  <P>Gebietslos 6: AOK Bremen/Bremerhaven, AOK – Die Gesundheitskasse für Niedersachsen, AOK Sachsen-Anhalt – Die Gesundheitskasse;</P>
                  <P>Gebietslos 7: AOK Nordost – Die Gesundheitskasse;</P>
                  <P>Gebietslos 8: AOK Rheinland-Pfalz/Saarland – Die Gesundheitskasse.</P>
                  <P>Darüber hinaus gelten die näheren Angaben zu den Fachlosen in den Vergabeunterlagen.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <TITLE>
                  <P>Dexamethason</P>
               </TITLE>
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="3">
               <TITLE>
                  <P>Metformin</P>
               </TITLE>
               <LOT_NO>3</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="4">
               <TITLE>
                  <P>Metoprolol</P>
               </TITLE>
               <LOT_NO>4</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="5">
               <TITLE>
                  <P>Olanzapin</P>
               </TITLE>
               <LOT_NO>5</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="6">
               <TITLE>
                  <P>Aciclovir</P>
               </TITLE>
               <LOT_NO>6</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="7">
               <TITLE>
                  <P>Atorvastatin</P>
               </TITLE>
               <LOT_NO>7</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="8">
               <TITLE>
                  <P>Bezafibrat</P>
               </TITLE>
               <LOT_NO>8</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="9">
               <TITLE>
                  <P>Brinzolamid</P>
               </TITLE>
               <LOT_NO>9</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="10">
               <TITLE>
                  <P>Budesonid</P>
               </TITLE>
               <LOT_NO>10</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="11">
               <TITLE>
                  <P>Candesartan+Hydrochlorothiazid</P>
               </TITLE>
               <LOT_NO>11</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="12">
               <TITLE>
                  <P>Capecitabin</P>
               </TITLE>
               <LOT_NO>12</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="13">
               <TITLE>
                  <P>Ciclopirox</P>
               </TITLE>
               <LOT_NO>13</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="14">
               <TITLE>
                  <P>Clonidin</P>
               </TITLE>
               <LOT_NO>14</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="15">
               <TITLE>
                  <P>Clopidogrel</P>
               </TITLE>
               <LOT_NO>15</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="16">
               <TITLE>
                  <P>Clozapin</P>
               </TITLE>
               <LOT_NO>16</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="17">
               <TITLE>
                  <P>Donepezil</P>
               </TITLE>
               <LOT_NO>17</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="18">
               <TITLE>
                  <P>Duloxetin BIK (Mindestindikation: Belastungsinkontinenz)</P>
               </TITLE>
               <LOT_NO>18</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="19">
               <TITLE>
                  <P>Duloxetin NPS (Mindestindikation: Schmerz bei Neuropathie)</P>
               </TITLE>
               <LOT_NO>19</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="20">
               <TITLE>
                  <P>Enalapril+Lercanidipin</P>
               </TITLE>
               <LOT_NO>20</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="21">
               <TITLE>
                  <P>Entecavir</P>
               </TITLE>
               <LOT_NO>21</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="22">
               <TITLE>
                  <P>Etoricoxib</P>
               </TITLE>
               <LOT_NO>22</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="23">
               <TITLE>
                  <P>Exemestan (nur Sexualhormone und Hemmstoffe)</P>
               </TITLE>
               <LOT_NO>23</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="24">
               <TITLE>
                  <P>Fulvestrant</P>
               </TITLE>
               <LOT_NO>24</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="25">
               <TITLE>
                  <P>Galantamin (keine Starterpacks)</P>
               </TITLE>
               <LOT_NO>25</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="26">
               <TITLE>
                  <P>Gentamicin</P>
               </TITLE>
               <LOT_NO>26</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="27">
               <TITLE>
                  <P>Glyceroltrinitrat (nur Sprays und Lösungen)</P>
               </TITLE>
               <LOT_NO>27</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="28">
               <TITLE>
                  <P>Hydrochlorothiazid+Triamteren</P>
               </TITLE>
               <LOT_NO>28</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="29">
               <TITLE>
                  <P>Ipratropiumbromid</P>
               </TITLE>
               <LOT_NO>29</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="30">
               <TITLE>
                  <P>Irbesartan+Hydrochlorothiazid</P>
               </TITLE>
               <LOT_NO>30</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="31">
               <TITLE>
                  <P>Lamivudin</P>
               </TITLE>
               <LOT_NO>31</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="32">
               <TITLE>
                  <P>Latanoprost</P>
               </TITLE>
               <LOT_NO>32</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="33">
               <TITLE>
                  <P>Letrozol (nur Sexualhormone und Hemmstoffe)</P>
               </TITLE>
               <LOT_NO>33</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="34">
               <TITLE>
                  <P>Levofloxacin</P>
               </TITLE>
               <LOT_NO>34</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="35">
               <TITLE>
                  <P>Levomepromazin</P>
               </TITLE>
               <LOT_NO>35</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="36">
               <TITLE>
                  <P>Levonorgestrel+Ethinylestradiol</P>
               </TITLE>
               <LOT_NO>36</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="37">
               <TITLE>
                  <P>Lovastatin</P>
               </TITLE>
               <LOT_NO>37</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="38">
               <TITLE>
                  <P>Naproxen</P>
               </TITLE>
               <LOT_NO>38</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="39">
               <TITLE>
                  <P>Nebivolol</P>
               </TITLE>
               <LOT_NO>39</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="40">
               <TITLE>
                  <P>Nevirapin</P>
               </TITLE>
               <LOT_NO>40</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="41">
               <TITLE>
                  <P>Progesteron (nur Weichkapseln)</P>
               </TITLE>
               <LOT_NO>41</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="42">
               <TITLE>
                  <P>Quetiapin (keine Starterpacks)</P>
               </TITLE>
               <LOT_NO>42</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="43">
               <TITLE>
                  <P>Raloxifen</P>
               </TITLE>
               <LOT_NO>43</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="44">
               <TITLE>
                  <P>Ramipril+Piretanid</P>
               </TITLE>
               <LOT_NO>44</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="45">
               <TITLE>
                  <P>Rasagilin</P>
               </TITLE>
               <LOT_NO>45</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="46">
               <TITLE>
                  <P>Ribavirin</P>
               </TITLE>
               <LOT_NO>46</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="47">
               <TITLE>
                  <P>Rivastigmin</P>
               </TITLE>
               <LOT_NO>47</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="48">
               <TITLE>
                  <P>Rizatriptan</P>
               </TITLE>
               <LOT_NO>48</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="49">
               <TITLE>
                  <P>Salmeterol+Fluticason</P>
               </TITLE>
               <LOT_NO>49</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="50">
               <TITLE>
                  <P>Telmisartan</P>
               </TITLE>
               <LOT_NO>50</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="51">
               <TITLE>
                  <P>Tenofovir disoproxil (nur Filmtabletten mit der Wirkstärke 245mg)</P>
               </TITLE>
               <LOT_NO>51</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="52">
               <TITLE>
                  <P>Tenofovir disoproxil+Emtricitabin</P>
               </TITLE>
               <LOT_NO>52</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="53">
               <TITLE>
                  <P>Ticlopidin</P>
               </TITLE>
               <LOT_NO>53</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="54">
               <TITLE>
                  <P>Tilidin+Naloxon</P>
               </TITLE>
               <LOT_NO>54</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="55">
               <TITLE>
                  <P>Timolol+Latanoprost</P>
               </TITLE>
               <LOT_NO>55</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="56">
               <TITLE>
                  <P>Tolcapon</P>
               </TITLE>
               <LOT_NO>56</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="57">
               <TITLE>
                  <P>Valganciclovir (nur Filmtabletten)</P>
               </TITLE>
               <LOT_NO>57</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="58">
               <TITLE>
                  <P>Valsartan</P>
               </TITLE>
               <LOT_NO>58</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="59">
               <TITLE>
                  <P>Valsartan+Amlodipin</P>
               </TITLE>
               <LOT_NO>59</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="60">
               <TITLE>
                  <P>Valsartan+Hydrochlorothiazid</P>
               </TITLE>
               <LOT_NO>60</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="61">
               <TITLE>
                  <P>Ziprasidon</P>
               </TITLE>
               <LOT_NO>61</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="62">
               <TITLE>
                  <P>Zoledronsäure (nur 4mg-Wirkstärke)</P>
               </TITLE>
               <LOT_NO>62</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="DE"/>
               <SHORT_DESCR>
                  <P>S.o., zur Beschreibung der Beschaffung zum Fachlos Candesartan (Fachlos Nr. 1).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <FRAMEWORK/>
            <NO_CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 240-497692</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>1</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>Candesartan – alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>7</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>TAD Pharma GmbH</OFFICIALNAME>
                     <TOWN>Cuxhaven</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="2">
            <CONTRACT_NO>2</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>Candesartan – alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>7</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heumann Pharma Gmbh &amp; Co. Generica KG (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heunet Pharma GmbH (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="3">
            <CONTRACT_NO>3</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>Candesartan – alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>7</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan dura GmbH (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Darmstadt</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan Healthcare GmbH (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Hannover</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>MEDA Pharma GmbH &amp; Co. KG (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Bad Homburg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="4">
            <CONTRACT_NO>4</CONTRACT_NO>
            <LOT_NO>2</LOT_NO>
            <TITLE>
               <P>Dexamethason – alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Galenpharma GmbH</OFFICIALNAME>
                     <TOWN>Kiel</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="5">
            <CONTRACT_NO>5</CONTRACT_NO>
            <LOT_NO>2</LOT_NO>
            <TITLE>
               <P>Dexamethason – alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ratiopharm GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>AbZ-Pharma GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Teva GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="6">
            <CONTRACT_NO>6</CONTRACT_NO>
            <LOT_NO>3</LOT_NO>
            <TITLE>
               <P>Metformin – alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Zentiva Pharma GmbH (BG Zentiva/Sanofi GbR)</OFFICIALNAME>
                     <TOWN>Berlin</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Sanofi-Aventis Deutschland GmbH (BG Zentiva/Sanofi GbR)</OFFICIALNAME>
                     <TOWN>Berlin</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="7">
            <CONTRACT_NO>7</CONTRACT_NO>
            <LOT_NO>3</LOT_NO>
            <TITLE>
               <P>Metformin – alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>axcount Generika GmbH</OFFICIALNAME>
                     <TOWN>Friedrichsdorf</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="8">
            <CONTRACT_NO>8</CONTRACT_NO>
            <LOT_NO>3</LOT_NO>
            <TITLE>
               <P>Metformin – alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Hexal AG (BG Hexal 1 A Pharma GbR)</OFFICIALNAME>
                     <TOWN>Holzkirchen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>1 A Pharma GmbH (BG Hexal 1 A Pharma GbR)</OFFICIALNAME>
                     <TOWN>Oberhaching</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="9">
            <CONTRACT_NO>9</CONTRACT_NO>
            <LOT_NO>4</LOT_NO>
            <TITLE>
               <P>Metoprolol - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>TEVA GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ratiopharm GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>AbZ-Pharma GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="10">
            <CONTRACT_NO>10</CONTRACT_NO>
            <LOT_NO>4</LOT_NO>
            <TITLE>
               <P>Metoprolol - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan dura GmbH (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Darmstadt</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan Healthcare GmbH (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Hannover</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>MEDA Pharma GmbH &amp; Co. KG (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Bad Homburg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="11">
            <CONTRACT_NO>11</CONTRACT_NO>
            <LOT_NO>4</LOT_NO>
            <TITLE>
               <P>Metoprolol - Gebietslose 1-7</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Hexal AG (BG Hexal 1 A Pharma GbR)</OFFICIALNAME>
                     <TOWN>Holzkirchen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>1 A Pharma GmbH (BG Hexal 1 A Pharma GbR)</OFFICIALNAME>
                     <TOWN>Oberhaching</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="12">
            <CONTRACT_NO>12</CONTRACT_NO>
            <LOT_NO>4</LOT_NO>
            <TITLE>
               <P>Metoprolol - Gebietslos 8</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ALIUD PHARMA GmbH</OFFICIALNAME>
                     <TOWN>Laichingen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="13">
            <CONTRACT_NO>13</CONTRACT_NO>
            <LOT_NO>5</LOT_NO>
            <TITLE>
               <P>Olanzapin - Gebietslose 1-5</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>8</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>PUREN Pharma GmbH &amp; Co. KG (BG PUREN/Aurobindo GbR)</OFFICIALNAME>
                     <TOWN>München</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Aurobindo Pharma GmbH (BG PUREN/Aurobindo GbR)</OFFICIALNAME>
                     <TOWN>München</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="14">
            <CONTRACT_NO>14</CONTRACT_NO>
            <LOT_NO>5</LOT_NO>
            <TITLE>
               <P>Olanzapin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>8</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Basics GmbH</OFFICIALNAME>
                     <TOWN>Leverkusen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="15">
            <CONTRACT_NO>15</CONTRACT_NO>
            <LOT_NO>5</LOT_NO>
            <TITLE>
               <P>Olanzapin - Gebietslose 6-8</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>8</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heumann Pharma Gmbh &amp; Co. Generica KG (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heunet Pharma GmbH (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="16">
            <CONTRACT_NO>16</CONTRACT_NO>
            <LOT_NO>5</LOT_NO>
            <TITLE>
               <P>Olanzapin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>8</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Glenmark Pharmaceuticals Europe Limited</OFFICIALNAME>
                     <TOWN>Watford</TOWN>
                     <COUNTRY VALUE="UK"/>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="17">
            <CONTRACT_NO>17</CONTRACT_NO>
            <LOT_NO>6</LOT_NO>
            <TITLE>
               <P>Aciclovir - Gebietslose 1-4, 6, 8</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Basics GmbH</OFFICIALNAME>
                     <TOWN>Leverkusen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="18">
            <CONTRACT_NO>18</CONTRACT_NO>
            <LOT_NO>6</LOT_NO>
            <TITLE>
               <P>Aciclovir - Gebietslose 5, 7</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ALIUD PHARMA GmbH</OFFICIALNAME>
                     <TOWN>Laichingen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="19">
            <CONTRACT_NO>19</CONTRACT_NO>
            <LOT_NO>7</LOT_NO>
            <TITLE>
               <P>Atorvastatin - Gebietslos 1</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>7</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Basics GmbH</OFFICIALNAME>
                     <TOWN>Leverkusen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="20">
            <CONTRACT_NO>20</CONTRACT_NO>
            <LOT_NO>7</LOT_NO>
            <TITLE>
               <P>Atorvastatin - Gebietslose 2-8</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>7</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Accord Healthcare Ltd. vertreten durch Accord Healthcare GmbH</OFFICIALNAME>
                     <TOWN>Freilassing</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="21">
            <CONTRACT_NO>21</CONTRACT_NO>
            <LOT_NO>8</LOT_NO>
            <TITLE>
               <P>Bezafibrat - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ALIUD PHARMA GmbH</OFFICIALNAME>
                     <TOWN>Laichingen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="22">
            <CONTRACT_NO>22</CONTRACT_NO>
            <LOT_NO>9</LOT_NO>
            <TITLE>
               <P>Brinzolamid - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heumann Pharma Gmbh &amp; Co. Generica KG (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heunet Pharma GmbH (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="23">
            <CONTRACT_NO>23</CONTRACT_NO>
            <LOT_NO>10</LOT_NO>
            <TITLE>
               <P>Budesonid - Gebietslose 1-4, 6, 7</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>INFECTOPHARM Arzneimittel und Consilium GmbH (BG INFECTOPHARM/Chiesi/MEDA)</OFFICIALNAME>
                     <TOWN>Heppenheim</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Chiesi GmbH (BG INFECTOPHARM/Chiesi/MEDA)</OFFICIALNAME>
                     <TOWN>Hamburg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>MEDA Pharma GmbH &amp; Co. KG (BG INFECTOPHARM/Chiesi/MEDA)</OFFICIALNAME>
                     <TOWN>Bad Homburg v. d. Höhe</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="24">
            <CONTRACT_NO>24</CONTRACT_NO>
            <LOT_NO>10</LOT_NO>
            <TITLE>
               <P>Budesonid - Gebietslose 5, 8</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ORION Pharma GmbH</OFFICIALNAME>
                     <TOWN>Hamburg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="25">
            <CONTRACT_NO>25</CONTRACT_NO>
            <LOT_NO>11</LOT_NO>
            <TITLE>
               <P>Candesartan+Hydrochlorothiazid - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>5</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>TAD Pharma GmbH</OFFICIALNAME>
                     <TOWN>Cuxhaven</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="26">
            <CONTRACT_NO>26</CONTRACT_NO>
            <LOT_NO>12</LOT_NO>
            <TITLE>
               <P>Capecitabin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Accord Healthcare Ltd. vertreten durch Accord Healthcare GmbH</OFFICIALNAME>
                     <TOWN>Freilassing</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="27">
            <CONTRACT_NO>27</CONTRACT_NO>
            <LOT_NO>13</LOT_NO>
            <TITLE>
               <P>Ciclopirox - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ratiopharm GmbH (BG TEVA ratiopharm (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>AbZ-Pharma GmbH (BG TEVA ratiopharm (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Teva GmbH (BG TEVA ratiopharm (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="28">
            <CONTRACT_NO>28</CONTRACT_NO>
            <LOT_NO>14</LOT_NO>
            <TITLE>
               <P>Clonidin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ratiopharm GmbH (BG TEVA ratiopharm (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>AbZ-Pharma GmbH (BG TEVA ratiopharm (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Teva GmbH (BG TEVA ratiopharm (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="29">
            <CONTRACT_NO>29</CONTRACT_NO>
            <LOT_NO>15</LOT_NO>
            <TITLE>
               <P>Clopidogrel - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>11</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Zentiva Pharma GmbH (BG Zentiva/Sanofi GbR)</OFFICIALNAME>
                     <TOWN>Berlin</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Sanofi-Aventis Deutschland GmbH (BG Zentiva/Sanofi GbR)</OFFICIALNAME>
                     <TOWN>Berlin</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="30">
            <CONTRACT_NO>30</CONTRACT_NO>
            <LOT_NO>16</LOT_NO>
            <TITLE>
               <P>Clozapin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>5</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>neuraxpharm Arzneimittel GmbH</OFFICIALNAME>
                     <TOWN>Langenfeld</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="31">
            <CONTRACT_NO>31</CONTRACT_NO>
            <LOT_NO>17</LOT_NO>
            <TITLE>
               <P>Donepezil - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>10</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Basics GmbH</OFFICIALNAME>
                     <TOWN>Leverkusen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="32">
            <CONTRACT_NO>32</CONTRACT_NO>
            <LOT_NO>18</LOT_NO>
            <TITLE>
               <P>Duloxetin BIK (Mindestindikation: Belastungsinkontinenz) - Gebietslose 1-5</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>8</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>PUREN Pharma GmbH &amp; Co. KG (BG PUREN/Aurobindo GbR)</OFFICIALNAME>
                     <TOWN>München</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Aurobindo Pharma GmbH (BG PUREN/Aurobindo GbR)</OFFICIALNAME>
                     <TOWN>München</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="33">
            <CONTRACT_NO>33</CONTRACT_NO>
            <LOT_NO>18</LOT_NO>
            <TITLE>
               <P>Duloxetin BIK (Mindestindikation: Belastungsinkontinenz) - Gebietslose 6-8</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>8</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Glenmark Arzneimittel GmbH</OFFICIALNAME>
                     <TOWN>Gröbenzell</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="34">
            <CONTRACT_NO>34</CONTRACT_NO>
            <LOT_NO>19</LOT_NO>
            <TITLE>
               <P>Duloxetin NPS (Mindestindikation: Schmerz bei Neuropathie) - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>10</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>TAD Pharma GmbH</OFFICIALNAME>
                     <TOWN>Cuxhaven</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="35">
            <CONTRACT_NO>35</CONTRACT_NO>
            <LOT_NO>20</LOT_NO>
            <TITLE>
               <P>Enalapril+Lercanidipin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>5</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Recordati Pharma GmbH</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="36">
            <CONTRACT_NO>36</CONTRACT_NO>
            <LOT_NO>21</LOT_NO>
            <TITLE>
               <P>Entecavir - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>9</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Cipla Europe NV</OFFICIALNAME>
                     <TOWN>Antwerp</TOWN>
                     <COUNTRY VALUE="BE"/>
                     <n2016:NUTS CODE="BE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="37">
            <CONTRACT_NO>37</CONTRACT_NO>
            <LOT_NO>22</LOT_NO>
            <TITLE>
               <P>Etoricoxib - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>10</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heumann Pharma Gmbh &amp; Co. Generica KG (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heunet Pharma GmbH (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="38">
            <CONTRACT_NO>38</CONTRACT_NO>
            <LOT_NO>23</LOT_NO>
            <TITLE>
               <P>Exemestan (nur Sexualhormone und Hemmstoffe) - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>8</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heumann Pharma Gmbh &amp; Co. Generica KG (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heunet Pharma GmbH (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="39">
            <CONTRACT_NO>39</CONTRACT_NO>
            <LOT_NO>24</LOT_NO>
            <TITLE>
               <P>Fulvestrant - alle Gebietslose</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_DISCONTINUED/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="40">
            <CONTRACT_NO>40</CONTRACT_NO>
            <LOT_NO>25</LOT_NO>
            <TITLE>
               <P>Galantamin (keine Starterpacks) - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>5</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heumann Pharma Gmbh &amp; Co. Generica KG (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heunet Pharma GmbH (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="41">
            <CONTRACT_NO>41</CONTRACT_NO>
            <LOT_NO>26</LOT_NO>
            <TITLE>
               <P>Gentamicin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Dr. Robert Winzer Pharma GmbH</OFFICIALNAME>
                     <TOWN>Berlin</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="42">
            <CONTRACT_NO>42</CONTRACT_NO>
            <LOT_NO>27</LOT_NO>
            <TITLE>
               <P>Glyceroltrinitrat (nur Sprays und Lösungen) - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>G. Pohl-Boskamp GmbH &amp; Co. KG</OFFICIALNAME>
                     <TOWN>Hohenlockstedt</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="43">
            <CONTRACT_NO>43</CONTRACT_NO>
            <LOT_NO>28</LOT_NO>
            <TITLE>
               <P>Hydrochlorothiazid+Triamteren - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>AAA-Pharma GmbH</OFFICIALNAME>
                     <TOWN>Böblingen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="44">
            <CONTRACT_NO>44</CONTRACT_NO>
            <LOT_NO>29</LOT_NO>
            <TITLE>
               <P>Ipratropiumbromid - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Teva GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ratiopharm GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>AbZ-Pharma GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="45">
            <CONTRACT_NO>45</CONTRACT_NO>
            <LOT_NO>30</LOT_NO>
            <TITLE>
               <P>Irbesartan+Hydrochlorothiazid - Gebietslose 1-3</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>8</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heumann Pharma Gmbh &amp; Co. Generica KG (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heunet Pharma GmbH (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="46">
            <CONTRACT_NO>46</CONTRACT_NO>
            <LOT_NO>30</LOT_NO>
            <TITLE>
               <P>Irbesartan+Hydrochlorothiazid - Gebietslose 4-6, 8</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>8</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Basics GmbH</OFFICIALNAME>
                     <TOWN>Leverkusen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="47">
            <CONTRACT_NO>47</CONTRACT_NO>
            <LOT_NO>30</LOT_NO>
            <TITLE>
               <P>Irbesartan+Hydrochlorothiazid - Gebietslos 7</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>8</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>PUREN Pharma GmbH &amp; Co. KG (BG PUREN/Aurobindo GbR)</OFFICIALNAME>
                     <TOWN>München</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Aurobindo Pharma GmbH (BG PUREN/Aurobindo GbR)</OFFICIALNAME>
                     <TOWN>München</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="48">
            <CONTRACT_NO>48</CONTRACT_NO>
            <LOT_NO>31</LOT_NO>
            <TITLE>
               <P>Lamivudin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan dura GmbH (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Darmstadt</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan Healthcare GmbH (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Hannover</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>MEDA Pharma GmbH &amp; Co. KG (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Bad Homburg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="49">
            <CONTRACT_NO>49</CONTRACT_NO>
            <LOT_NO>32</LOT_NO>
            <TITLE>
               <P>Latanoprost - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Pfizer Pharma PFE GmbH</OFFICIALNAME>
                     <TOWN>Berlin</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="50">
            <CONTRACT_NO>50</CONTRACT_NO>
            <LOT_NO>33</LOT_NO>
            <TITLE>
               <P>Letrozol (nur Sexualhormone und Hemmstoffe) - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>10</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Accord Healthcare Ltd. vertreten durch Accord Healthcare GmbH</OFFICIALNAME>
                     <TOWN>Freilassing</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="51">
            <CONTRACT_NO>51</CONTRACT_NO>
            <LOT_NO>34</LOT_NO>
            <TITLE>
               <P>Levofloxacin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>PUREN Pharma GmbH &amp; Co. KG (BG PUREN/Aurobindo GbR)</OFFICIALNAME>
                     <TOWN>München</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Aurobindo Pharma GmbH (BG PUREN/Aurobindo GbR)</OFFICIALNAME>
                     <TOWN>München</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="52">
            <CONTRACT_NO>52</CONTRACT_NO>
            <LOT_NO>35</LOT_NO>
            <TITLE>
               <P>Levomepromazin - alle Gebietslose</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="53">
            <CONTRACT_NO>53</CONTRACT_NO>
            <LOT_NO>36</LOT_NO>
            <TITLE>
               <P>Levonorgestrel+Ethinylestradiol - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan dura GmbH (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Darmstadt</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan Healthcare GmbH (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Hannover</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>MEDA Pharma GmbH &amp; Co. KG (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Bad Homburg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="54">
            <CONTRACT_NO>54</CONTRACT_NO>
            <LOT_NO>37</LOT_NO>
            <TITLE>
               <P>Lovastatin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Teva GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ratiopharm GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>AbZ-Pharma GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="55">
            <CONTRACT_NO>55</CONTRACT_NO>
            <LOT_NO>38</LOT_NO>
            <TITLE>
               <P>Naproxen - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ALIUD PHARMA GmbH</OFFICIALNAME>
                     <TOWN>Laichingen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="56">
            <CONTRACT_NO>56</CONTRACT_NO>
            <LOT_NO>39</LOT_NO>
            <TITLE>
               <P>Nebivolol - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Glenmark Arzneimittel GmbH</OFFICIALNAME>
                     <TOWN>Gröbenzell</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="57">
            <CONTRACT_NO>57</CONTRACT_NO>
            <LOT_NO>40</LOT_NO>
            <TITLE>
               <P>Nevirapin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Accord Healthcare Ltd. vertreten durch Accord Healthcare GmbH</OFFICIALNAME>
                     <TOWN>Freilassing</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="58">
            <CONTRACT_NO>58</CONTRACT_NO>
            <LOT_NO>41</LOT_NO>
            <TITLE>
               <P>Progesteron (nur Weichkapseln) - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>DR. KADE/BESINS Pharma GmbH</OFFICIALNAME>
                     <TOWN>Berlin</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="59">
            <CONTRACT_NO>59</CONTRACT_NO>
            <LOT_NO>42</LOT_NO>
            <TITLE>
               <P>Quetiapin (keine Starterpacks) - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>8</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Accord Healthcare Ltd. vertreten durch Accord Healthcare GmbH (BG ACCORD/GLENMARK GbR)</OFFICIALNAME>
                     <TOWN>Freilassing</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Glenmark Arzneimittel GmbH (BG ACCORD/GLENMARK GbR)</OFFICIALNAME>
                     <TOWN>Gröbenzell</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="60">
            <CONTRACT_NO>60</CONTRACT_NO>
            <LOT_NO>43</LOT_NO>
            <TITLE>
               <P>Raloxifen - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ALIUD PHARMA GmbH</OFFICIALNAME>
                     <TOWN>Laichingen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="61">
            <CONTRACT_NO>61</CONTRACT_NO>
            <LOT_NO>44</LOT_NO>
            <TITLE>
               <P>Ramipril+Piretanid - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Zentiva Pharma GmbH (BG Zentiva/Sanofi GbR)</OFFICIALNAME>
                     <TOWN>Berlin</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Sanofi-Aventis Deutschland GmbH (BG Zentiva/Sanofi GbR)</OFFICIALNAME>
                     <TOWN>Berlin</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="62">
            <CONTRACT_NO>62</CONTRACT_NO>
            <LOT_NO>45</LOT_NO>
            <TITLE>
               <P>Rasagilin - Gebietslose 1-4, 6-8</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>14</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Micro Labs GmbH</OFFICIALNAME>
                     <TOWN>Frankfurt</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="63">
            <CONTRACT_NO>63</CONTRACT_NO>
            <LOT_NO>45</LOT_NO>
            <TITLE>
               <P>Rasagilin - Gebietslos 5</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>14</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Glenmark Arzneimittel GmbH</OFFICIALNAME>
                     <TOWN>Gröbenzell</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="64">
            <CONTRACT_NO>64</CONTRACT_NO>
            <LOT_NO>46</LOT_NO>
            <TITLE>
               <P>Ribavirin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Teva GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ratiopharm GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>AbZ-Pharma GmbH (BG TEVA ratiopharm GbR (AbZ, ratiopharm, Teva))</OFFICIALNAME>
                     <TOWN>Ulm</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="65">
            <CONTRACT_NO>65</CONTRACT_NO>
            <LOT_NO>47</LOT_NO>
            <TITLE>
               <P>Rivastigmin - alle Gebietslose</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_DISCONTINUED/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="66">
            <CONTRACT_NO>66</CONTRACT_NO>
            <LOT_NO>48</LOT_NO>
            <TITLE>
               <P>Rizatriptan - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Glenmark Arzneimittel GmbH</OFFICIALNAME>
                     <TOWN>Gröbenzell</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="67">
            <CONTRACT_NO>67</CONTRACT_NO>
            <LOT_NO>49</LOT_NO>
            <TITLE>
               <P>Salmeterol+Fluticason - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GlaxoSmithKline GmbH &amp; Co. KG</OFFICIALNAME>
                     <TOWN>München</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="68">
            <CONTRACT_NO>68</CONTRACT_NO>
            <LOT_NO>50</LOT_NO>
            <TITLE>
               <P>Telmisartan - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>7</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heumann Pharma Gmbh &amp; Co. Generica KG (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heunet Pharma GmbH (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="69">
            <CONTRACT_NO>69</CONTRACT_NO>
            <LOT_NO>51</LOT_NO>
            <TITLE>
               <P>Tenofovir disoproxil (nur Filmtabletten mit der Wirkstärke 245mg) - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>9</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Cipla Europe NV</OFFICIALNAME>
                     <TOWN>Antwerp</TOWN>
                     <COUNTRY VALUE="BE"/>
                     <n2016:NUTS CODE="BE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="70">
            <CONTRACT_NO>70</CONTRACT_NO>
            <LOT_NO>52</LOT_NO>
            <TITLE>
               <P>Tenofovir disoproxil+Emtricitabin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>8</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Zentiva Pharma GmbH (BG Zentiva/Sanofi GbR)</OFFICIALNAME>
                     <TOWN>Berlin</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Sanofi-Aventis Deutschland GmbH (BG Zentiva/Sanofi GbR)</OFFICIALNAME>
                     <TOWN>Berlin</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="71">
            <CONTRACT_NO>71</CONTRACT_NO>
            <LOT_NO>53</LOT_NO>
            <TITLE>
               <P>Ticlopidin - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ALIUD PHARMA GmbH</OFFICIALNAME>
                     <TOWN>Laichingen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="72">
            <CONTRACT_NO>72</CONTRACT_NO>
            <LOT_NO>54</LOT_NO>
            <TITLE>
               <P>Tilidin+Naloxon - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ALIUD PHARMA GmbH</OFFICIALNAME>
                     <TOWN>Laichingen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="73">
            <CONTRACT_NO>73</CONTRACT_NO>
            <LOT_NO>55</LOT_NO>
            <TITLE>
               <P>Timolol+Latanoprost - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Pfizer Pharma PFE GmbH</OFFICIALNAME>
                     <TOWN>Berlin</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="74">
            <CONTRACT_NO>74</CONTRACT_NO>
            <LOT_NO>56</LOT_NO>
            <TITLE>
               <P>Tolcapon - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>neuraxpharm Arzneimittel GmbH</OFFICIALNAME>
                     <TOWN>Langenfeld</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="75">
            <CONTRACT_NO>75</CONTRACT_NO>
            <LOT_NO>57</LOT_NO>
            <TITLE>
               <P>Valganciclovir (nur Filmtabletten) - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heumann Pharma Gmbh &amp; Co. Generica KG (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Heunet Pharma GmbH (BG Heumann/Heunet GbR)</OFFICIALNAME>
                     <TOWN>Nürnberg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="76">
            <CONTRACT_NO>76</CONTRACT_NO>
            <LOT_NO>58</LOT_NO>
            <TITLE>
               <P>Valsartan - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan dura GmbH (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Darmstadt</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan Healthcare GmbH (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Hannover</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>MEDA Pharma GmbH &amp; Co. KG (Bietergemeinschaft Mylan/Meda GbR)</OFFICIALNAME>
                     <TOWN>Bad Homburg</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="77">
            <CONTRACT_NO>77</CONTRACT_NO>
            <LOT_NO>59</LOT_NO>
            <TITLE>
               <P>Valsartan+Amlodipin - alle Gebietslose</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_DISCONTINUED/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="78">
            <CONTRACT_NO>78</CONTRACT_NO>
            <LOT_NO>60</LOT_NO>
            <TITLE>
               <P>Valsartan+Hydrochlorothiazid - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>5</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>TAD Pharma GmbH</OFFICIALNAME>
                     <TOWN>Cuxhaven</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="79">
            <CONTRACT_NO>79</CONTRACT_NO>
            <LOT_NO>61</LOT_NO>
            <TITLE>
               <P>Ziprasidon - Gebietslose 1-3, 5-7</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>5</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>PUREN Pharma GmbH &amp; Co. KG (BG PUREN/Aurobindo GbR)</OFFICIALNAME>
                     <TOWN>München</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Aurobindo Pharma GmbH (BG PUREN/Aurobindo GbR)</OFFICIALNAME>
                     <TOWN>München</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="80">
            <CONTRACT_NO>80</CONTRACT_NO>
            <LOT_NO>61</LOT_NO>
            <TITLE>
               <P>Ziprasidon - Gebietslose 4, 8</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>5</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>TAD Pharma GmbH</OFFICIALNAME>
                     <TOWN>Cuxhaven</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="81">
            <CONTRACT_NO>81</CONTRACT_NO>
            <LOT_NO>62</LOT_NO>
            <TITLE>
               <P>Zoledronsäure (nur 4mg-Wirkstärke) - alle Gebietslose</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-27</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>ALIUD PHARMA GmbH</OFFICIALNAME>
                     <TOWN>Laichingen</TOWN>
                     <COUNTRY VALUE="DE"/>
                     <n2016:NUTS CODE="DE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">209000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">209000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <INFO_ADD>
               <P>Die AOK Baden-Württemberg führt diese Ausschreibung im eigenen Namen sowie namens der folgenden AOKs durch:</P>
               <P>1) AOK Bayern – Die Gesundheitskasse;</P>
               <P>2) AOK Bremen/Bremerhaven;</P>
               <P>3) AOK – Die Gesundheitskasse in Hessen;</P>
               <P>4) AOK – Die Gesundheitskasse für Niedersachsen;</P>
               <P>5) AOK Nordost – Die Gesundheitskasse;</P>
               <P>6) AOK NordWest – Die Gesundheitskasse;</P>
               <P>7) AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen;</P>
               <P>8) AOK Rheinland/Hamburg – Die Gesundheitskasse;</P>
               <P>9) AOK Rheinland-Pfalz/Saarland – Die Gesundheitskasse;</P>
               <P>10) AOK Sachsen-Anhalt – Die Gesundheitskasse.</P>
               <P>Der Preis ist, wie in der Auftragsbekanntmachung ABl. EU 2017/S 240-497692 angegeben, nicht das einzige Zuschlagskriterium; alle Kriterien sind nur in den Beschaffungsunterlagen aufgeführt. Die ausschließliche Angabe „Preis“ jeweils in den Abschnitten II.2.5) zu den einzelnen Auftragsvergaben ist den Formularanforderungen geschuldet.</P>
               <P>Bekanntmachungs-ID: CXP4YH0YAW4</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Vergabekammern des Bundes beim Bundeskartellamt</OFFICIALNAME>
               <ADDRESS>Villemombler Straße 76</ADDRESS>
               <TOWN>Bonn</TOWN>
               <POSTAL_CODE>53123</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <FAX>+49 2289499163</FAX>
            </ADDRESS_REVIEW_BODY>
            <REVIEW_PROCEDURE>
               <P>Für die Einlegung von Rechtsbehelfen gelten u. a. die folgenden Bestimmungen des Gesetzes gegen Wettbewerbsbeschränkungen (GWB) in der seit dem 18.4.2016 geltenden Fassung:</P>
               <P>§ 134 Informations- und Wartepflicht:</P>
               <P>(1) Öffentliche Auftraggeber haben die Bieter, deren Angebote nicht berücksichtigt werden sollen, über den Namen des Unternehmens, dessen Angebot angenommen werden soll, über die Gründe der vorgesehenen Nichtberücksichtigung ihres Angebots und über den frühesten Zeitpunkt des Vertragsschlusses unverzüglich in Textform zu informieren. Dies gilt auch für Bewerber, denen keine Information über die Ablehnung ihrer Bewerbung zur Verfügung gestellt wurde, bevor die Mitteilung über die Zuschlagsentscheidung an die betroffenen Bieter ergangen ist;</P>
               <P>(2) Ein Vertrag darf erst 15 Kalendertage nach Absendung der Information nach Absatz 1 geschlossen werden. Wird die Information auf elektronischem Weg oder per Fax versendet, verkürzt sich die Frist auf 10 Kalendertage. Die Frist beginnt am Tag nach der Absendung der Information durch den Auftraggeber; auf den Tag des Zugangs beim betroffenen Bieter und Bewerber kommt es nicht an. (3) […]</P>
               <P>§ 135 Unwirksamkeit:</P>
               <P>(1) Ein öffentlicher Auftrag ist von Anfang an unwirksam, wenn der öffentliche Auftraggeber 1. gegen § 134 verstoßen hat oder 2. den Auftrag ohne vorherige Veröffentlichung einer Bekanntmachung im Amtsblatt der Europäischen Union vergeben hat, ohne dass dies aufgrund Gesetzes gestattet ist, und dieser Verstoß in einem Nachprüfungsverfahren festgestellt worden ist; (2) Die Unwirksamkeit nach Absatz 1 kann nur festgestellt werden, wenn sie im Nachprüfungsverfahren innerhalb von 30 Kalendertagen nach der Information der betroffenen Bieter und Bewerber durch den öffentlichen Auftraggeber über den Abschluss des Vertrags, jedoch nicht später als 6 Monate nach Vertragsschluss geltend gemacht worden ist. Hat der Auftraggeber die Auftragsvergabe im Amtsblatt der Europäischen Union bekannt gemacht, endet die Frist zur Geltendmachung der Unwirksamkeit 30 Kalendertage nach Veröffentlichung der Bekanntmachung der Auftragsvergabe im Amtsblatt der Europäischen Union.</P>
               <P>§ 160 Einleitung, Antrag:</P>
               <P>(1) Die Vergabekammer leitet ein Nachprüfungsverfahren nur auf Antrag ein; </P>
               <P>(2) Antragsbefugt ist jedes Unternehmen, das ein Interesse an dem öffentlichen Auftrag oder der Konzession hat und eine Verletzung in seinen Rechten nach § 97 Absatz 6 durch Nichtbeachtung von Vergabevorschriften geltend macht. Dabei ist darzulegen, dass dem Unternehmen durch die behauptete Verletzung der Vergabevorschriften ein Schaden entstanden ist oder zu entstehen droht; </P>
               <P>(3) Der Antrag ist unzulässig, soweit: </P>
               <P>1. der Antragsteller den geltend gemachten Verstoß gegen Vergabevorschriften vor Einreichen des Nachprüfungsantrags erkannt und gegenüber dem Auftraggeber nicht innerhalb einer Frist von 10 Kalendertagen gerügt hat; der Ablauf der Frist nach § 134 Absatz 2 bleibt unberührt; </P>
               <P>2. Verstöße gegen Vergabevorschriften, die aufgrund der Bekanntmachung erkennbar sind, nicht spätestens bis zum Ablauf der in der Bekanntmachung benannten Frist zur Bewerbung oder zur Angebotsabgabe gegenüber dem Auftraggeber gerügt werden; </P>
               <P>3. Verstöße gegen Vergabevorschriften, die erst in den Vergabeunterlagen erkennbar sind, nicht spätestens bis zum Ablauf der Frist zur Bewerbung oder zur Angebotsabgabe</P>
               <P>Gegenüber dem Auftraggeber gerügt werden; </P>
               <P>4. mehr als 15 Kalendertage nach Eingang der Mitteilung des Auftraggebers, einer Rüge nicht abhelfen zu wollen, vergangen sind. […].</P>
               <P>§ 168 Entscheidung der Vergabekammer:</P>
               <P>(1) Die Vergabekammer entscheidet, ob der Antragsteller in seinen Rechten verletzt ist und trifft die geeigneten Maßnahmen, um eine Rechtsverletzung zu</P>
               <P>Beseitigen und eine Schädigung der betroffenen Interessen zu verhindern. Sie ist an die Anträge nicht gebunden und kann auch unabhängig davon auf die Rechtmäßigkeit des Vergabeverfahrens einwirken; </P>
               <P>(2) Ein wirksam erteilter Zuschlag kann nicht aufgehoben werden.</P>
            </REVIEW_PROCEDURE>
            <DATE_DISPATCH_NOTICE>2018-04-12</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
